Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
CARDIOSTIM
Primedic

Innovative Chair Allows Patients to Sit During Cancer Treatments

By HospiMedica International staff writers
Posted on 06 Dec 2012
A modified treatment chair used with cancer patients allows those who have problems lying down during procedures to sit upright, providing greater comfort.

The Procure intracranial chair was designed to address the difficulty some patients have when they need to lie flat for treatment. The chair also gives proton centers the option of using less expensive beam delivery systems rather than large gantry systems, as it was designed with multiple rotation points that complement the limited beam angles offered by the inclined or fixed beam systems. ProCure also developed the inclined beam technology, which can be used to treat approximately 80% of tumors that normally require the use of a gantry, but in a space about half the size, provided the chair can be attached to a robotic positioner. The intracranial chair was developed by Procure Treatment Centers (Procure, Bloomington, IN, USA).

“Some patients, especially those with head and neck tumors, have difficulty swallowing while lying on a standard treatment table,” said Eugen Hug, MD, medical director and chief medical officer at Procure. “Not only is this device helpful in greatly enhancing patient comfort but it improves patient flow by allowing us to use the inclined beam system for more people.”

“Our sole focus is providing exceptional patient care and we continue to do that by developing new innovations that place our patient’s comfort front and center,” said Niek Schreuder, senior vice president of medical physics and technology at ProCure. “Our engineers at the ProCure Training and Development Center strive to bring new and improved technology to cancer therapy, not only for our center but for all practices that are treating patients who could benefit.”

Proton therapy is an advanced form of radiation and an important alternative to standard X-ray radiation for many patients with cancer and for some noncancerous tumors. Proton therapy has been shown to be beneficial in the treatment of a broad range of tumor types including brain, central nervous system (CNS), gastrointestinal (GI), head and neck, lung, and prostate as well as sarcomas and many pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors such as base of skull and tumors along the spinal cord.

Related Links:
Procure Treatment Centers


Channels

Critical Care

view channel

Abdominal Aortic Aneurysms Screening Urged in Seniors

Two-thirds of deaths due to abdominal aortic aneurysm (AAA) rupture occur in people aged 75 and older and screening strategies should be updated to reflect the demographic shift, claims a new study. Researchers at John Radcliffe Hospital (Oxford, United Kingdom) and Oxford University (United Kingdom) conducted a prospective,... Read more

Women's Health

view channel

Elective Cesarean Section Risks Outweigh Benefits

A new review states that cesarean section is associated with increased risks to both mother and child, and should only be performed when it is clearly advantageous. Researchers at Ludwig-Maximilians-Universität (LMU; Munich, Germany) conducted a review of studies to understand the rising worldwide trend of elective cesarean... Read more

Hospital News

view channel
Image: The future site of the Springdale ACH campus on I-49, across from Arvest Ballpark (Photo courtesy of ACH).

Arkansas Children's Hospital to Develop Springdale Facility

Arkansas Children's Hospital (ACH; Little Rock, USA) has unveiled plans to develop a new hospital campus in Springdale, which will involve an investment of USD 184 million during the next five years.... Read more

Business

view channel
Image: The Centor 1-Clic vial (Photo courtesy of Centor).

Gerresheimer Buys Plastic Vials Maker Centor

Advanced healthcare glass and plastic products manufacturer Gerresheimer (Düsseldorf, Germany) has agreed to purchase plastic vial maker Centor (Perrysburg, OH, USA) for USD 725 million in cash.... Read more
 

Events

02 Sep 2015 - 05 Sep 2015
23 Sep 2015 - 25 Sep 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.